PPCB
Propanc Biopharma, Inc. Common Stock
NASDAQ: PPCB · HEALTHCARE · BIOTECHNOLOGY
$0.10
+2.40% today
Updated 2026-04-30
Market cap
$2.32M
P/E ratio
0.00
P/S ratio
—
EPS (TTM)
$52.11
Dividend yield
—
52W range
$0 – $11
Volume
3.9M
Propanc Biopharma, Inc. Common Stock (PPCB) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cost of revenue | $1828.00 | $1857.00 | $1792.00 | $4061.00 | $538.00 | $81.00 | $877.00 | $2166.00 | $2225.00 | $2306.00 | $2473.00 | $28112.00 | $5671.00 | $17760.00 | $21656.00 | — |
| Gross profit | $-1828.00 | $-1857.00 | $-1792.00 | $-4061.00 | $-538.00 | $-81.00 | $-877.00 | $-2166.00 | $-2225.00 | $-2306.00 | $-2473.00 | $-28112.00 | $-5671.00 | $-17760.00 | $-21656.00 | — |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | $34031.00 | $385777.00 | $5279.00 | $12344.00 | $8168.00 | $134319.00 | $1.45M | $971769.00 | $1.83M | $260335.00 | $179987.00 | $230956.00 | $256052.00 | $247919.00 | $248102.00 | $223721.00 |
| SG&A | — | — | $11.56M | $1.35M | $742036.00 | $1.57M | $5.43M | $4.74M | $2.10M | $2.33M | $3.28M | $1.58M | $1.74M | $1.53M | $1.29M | $57.05M |
| Operating income | $-726000.00 | $-2.24M | $-11.59M | $-1.36M | $-761221.00 | $-1.71M | $-6.90M | $-5.74M | $-3.96M | $-2.62M | $-3.49M | $-1.81M | $-1.99M | $-1.78M | $-1.54M | $-57.28M |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $-724000.00 | $-2.23M | $-11.60M | $-1.49M | $-784147.00 | $-2.17M | $-5.00M | $-4.97M | $-4.43M | $-4.56M | $-3.13M | $-1.69M | $-2.14M | $-2.23M | $-1.26M | $-58.34M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | $-725828.00 | $-2.24M | $-11.61M | $-1.50M | $-784685.00 | $-2.17M | $-5.00M | $-4.97M | $-4.43M | $-4.56M | $-3.13M | $-1.69M | $-2.14M | $-2.26M | $-1.28M | $-58.36M |
| Interest expense | $116674.00 | — | $2967.00 | $5465.00 | $93147.00 | $1.32M | $4.49M | $3.20M | $2.79M | $1.31M | $1.75M | $449457.00 | $568798.00 | $532821.00 | $665841.00 | $563757.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-842000.00 | $-2.15M | $-11.43M | $-1.44M | $-829564.00 | $-3.41M | $-9.41M | $-7.87M | $-7.04M | $-5.76M | $-4.74M | $-2.03M | $-2.66M | $-2.66M | $-1.82M | $-58.92M |
| Net income growth (YoY) | — | -155.6% | -431.3% | +87.4% | +42.5% | -311.4% | -175.7% | +16.4% | +10.5% | +18.2% | +17.7% | +57.3% | -31.2% | -0.1% | +31.6% | -3135.8% |
| Profit margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |